## Abstract Human T‐cell leukemia/lymphoma virus (HTLV)‐producing cells were lysed by peripheral mononuclear cells (PMNC) from both anti‐HTLV antibody‐positive and ‐negative healthy persons in the presence of natural humoral antibodies against HTLV‐related antigens (antibody‐dependent cellular cyto
Natural antibodies to human T-cell leukemia/lymphoma virus in healthy venezuelan populations
✍ Scribed by Fernando Merino; Marjorie Robert-Guroff; Jeffrey Clark; Marilena Biondo-Bracho; William A. Blattner; Robert C. Gallo
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- French
- Weight
- 615 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Serum samples of 769 healthy Venezuelan donors were assayed for natural antibodies to HTLV-I by the ELISA technique. Specific HTLV-I antibody prevalence was 6.8% but varied from 1% in Caracas to 13.7% in the Amazonas region and the State of Zulia. Adults infected with Trypanosoma cruzi had the highest HTLV-I antibody prevalence of 15%. Areas of high antibody prevalence were correlated most strongly with the presence of arthropod-borne diseases and to a lesser extent with socio-economic factors. Genetic factors were not correlated with antibody prevalence. Antibodies were seen in children as young as 3 years of age in the most endemic areas. Antibody titers increased with age, suggesting continuous exposure to the virus. The data provide clues for elucidation of the geographic variation in HTLV-I antibody prevalence seen Venezuela and other HTLV-I endemic areas. In addition, they further confirm the Caribbean region as being endemic for HTLV-I and extend this region to inland areas of South America.
📜 SIMILAR VOLUMES
## Abstract The adult T‐cell leukemia (ATL)‐associated antigen complex (ATLA) is recognized by serum antibodies of carriers of ATL virus (ATLV). ATLA consists mainly of ATLV polypeptides and their precursors. The sera from 22 ATL patients, 21 healthy carriers and 9 healthy individuals were examined
## Abstract The prevalence of HTLV‐I antibodies was evaluated in Jamaica among persons with various malignant, infectious, autoimmune and hematologic disorders and in clinically normal persons. Results document that: (1) the prevalence of HTLV‐I antibodies in this population increases with age; (2)
## Abstract Antibodies to Epstein‐Barr virus (EBV)‐capsid antigen (VCA), early antigen (EA) and EBV‐associated nuclear antigen (EBNA) in the sera of 103 patients with adult T‐cell leukemia (ATL) and the sera of 243 age‐ and sex‐matched healthy adults, namely 99 anti‐ATLA‐positive (antibodies to ATL